TTK Healthcare Merger & Restructuring Worth ₹256 Cr
TTK Healthcare completed the sale of its "EVA" and "Good Home" brands to Wipro Enterprises. The company received Rs. 256 crore in cash consideration.
- Value
- ₹256.0 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
9 announcements with these filters
TTK Healthcare completed the sale of its "EVA" and "Good Home" brands to Wipro Enterprises. The company received Rs. 256 crore in cash consideration.
TTK Healthcare Limited has appointed M/s. R V K & Co., Chartered Accountants, as the Company's Tax Auditor. The appointment is for a three-year term covering FY 2025-26 to 2027-28.
TTK Healthcare Ltd announced that its tax auditor, M/s Aiyar & Co., resigned effective August 26, 2026. The auditor cited eligibility issues regarding their peer review certificate.
TTK Healthcare Ltd reported revenue from operations of ₹257.6 Cr (+13.8% YoY) and net profit of ₹21.3 Cr (+63.8% YoY) for Q1 FY27.
TTK Healthcare has scheduled a board meeting for August 06, 2026, to approve the company's unaudited financial results for the first quarter ended June 30, 2026.
TTK Healthcare Limited announced the re-appointment of Mr. Thiruvallur Thattai Raghunathan as Executive Director. The appointment is effective from November 1, 2026, for a term of 60 months.
TTK Healthcare Ltd held its 68th Annual General Meeting via video conferencing. The meeting included the declaration of a dividend of Rs.10.00 per share.
TTK Healthcare has agreed to sell its EVA and Good Home brands to Mipro Enterprises Private Limited. The total consideration for the sale is ₹256 Crore.
TTK Healthcare Ltd submitted its quarterly shareholding pattern for the period ending June 30, 2026. The filing details holdings across promoter and public categories.